MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NxStage Medical Company Profile (NASDAQ:NXTM)

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $24.50 (30.04% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
Show:
DateFirmActionRatingPrice TargetActions
5/17/2016Piper JaffrayReiterated RatingOverweight$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Wells FargoReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016BTIG ResearchReiterated RatingBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2015Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Leerink SwannBoost Price Target$24.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha